1. Home
  2. PSTV vs ADN Comparison

PSTV vs ADN Comparison

Compare PSTV & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • ADN
  • Stock Information
  • Founded
  • PSTV 1996
  • ADN 2006
  • Country
  • PSTV United States
  • ADN United States
  • Employees
  • PSTV N/A
  • ADN N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • ADN Power Generation
  • Sector
  • PSTV Health Care
  • ADN Utilities
  • Exchange
  • PSTV Nasdaq
  • ADN Nasdaq
  • Market Cap
  • PSTV 9.9M
  • ADN 11.2M
  • IPO Year
  • PSTV N/A
  • ADN N/A
  • Fundamental
  • Price
  • PSTV $1.75
  • ADN $4.64
  • Analyst Decision
  • PSTV Strong Buy
  • ADN Hold
  • Analyst Count
  • PSTV 1
  • ADN 1
  • Target Price
  • PSTV $8.00
  • ADN $18.00
  • AVG Volume (30 Days)
  • PSTV 59.7K
  • ADN 27.1K
  • Earning Date
  • PSTV 08-12-2024
  • ADN 09-23-2024
  • Dividend Yield
  • PSTV N/A
  • ADN N/A
  • EPS Growth
  • PSTV N/A
  • ADN N/A
  • EPS
  • PSTV N/A
  • ADN N/A
  • Revenue
  • PSTV $6,084,000.00
  • ADN $5,310,000.00
  • Revenue This Year
  • PSTV $5.21
  • ADN N/A
  • Revenue Next Year
  • PSTV N/A
  • ADN $2,705.94
  • P/E Ratio
  • PSTV N/A
  • ADN N/A
  • Revenue Growth
  • PSTV 733.42
  • ADN N/A
  • 52 Week Low
  • PSTV $0.97
  • ADN $2.70
  • 52 Week High
  • PSTV $3.21
  • ADN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • ADN 69.89
  • Support Level
  • PSTV $1.62
  • ADN $3.70
  • Resistance Level
  • PSTV $1.92
  • ADN $4.74
  • Average True Range (ATR)
  • PSTV 0.17
  • ADN 0.43
  • MACD
  • PSTV 0.03
  • ADN 0.13
  • Stochastic Oscillator
  • PSTV 52.24
  • ADN 86.13

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: